Oct 28, 2021

Listen to Philip P. Goodney, MD, MS, Foluso A. Fakorede, MD and Peter A. Schneider, MD discuss the differences in preventive measures offered to patients with diabetes and peripheral artery disease (PAD) as well as better delivery of preventive measures to high-risk patients and high-risk regions in the United States.

Sep 28, 2021

Listen to Dr. Jennifer Green and Dr. Neha Pagidipati discuss the utilization of SGLT2i and GLP-1RA in the hospital setting in patients with indications for such therapy, as described in the 2021 ADA Standards of Medical Care and current AHA guidelines, including the recent ASA/AHA Recurrent Stroke prevention guidelines.

Jul 8, 2021

Listen to George L. Bakris, MD, FAHA, FASN, Cecilia C. Low Wang, MD, FACP and Neda Rasouli, MD educate clinicians on the updates made in the 2021 ADA Standards of Care related to metformin use and considerations for when the guideline recommends considering use of SGLT-2 Inhibitors and GLP-1 receptor agonists...

Mar 2, 2021

Listen to Dr. Boris Draznin, an endocrinologist and specialist in diabetes and internal medicine, and Dr. Pam Kushner, a specialist in family medicine discuss how the new American Diabetes Association’s 2021 Standards of Care have changed and implications for practice.